Literature DB >> 19262589

Could thrombolytic approaches in acute stroke benefit from stringent selection criteria?

Alexandre B Maulaz1, Rodrigo Targa Martins, Marlise de Castro Ribeiro, Renata Londero, José Otávio D Soares, Jefferson Gomes Fernandes.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19262589     DOI： 10.1038/ncpneuro1048

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN： 1745-834X


× No keyword cloud information.
  12 in total

1.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Refining the perfusion-diffusion mismatch hypothesis.

Authors:  K S Butcher; M Parsons; L MacGregor; P A Barber; J Chalk; C Bladin; C Levi; T Kimber; D Schultz; J Fink; B Tress; G Donnan; S Davis
Journal:  Stroke       Date:  2005-06       Impact factor: 7.914

3.  Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke.

Authors:  Tobias Neumann-Haefelin; Silke Hoelig; Joachim Berkefeld; Jens Fiehler; Achim Gass; Marek Humpich; Andreas Kastrup; Thomas Kucinski; Olivera Lecei; David S Liebeskind; Joachim Rother; Charlotte Rosso; Yves Samson; Jeffrey L Saver; Bernhard Yan
Journal:  Stroke       Date:  2006-08-24       Impact factor: 7.914

4.  Clinical importance of microbleeds in patients receiving IV thrombolysis.

Authors:  W Kakuda; V N Thijs; M G Lansberg; R Bammer; L Wechsler; S Kemp; M E Moseley; M P Marks; G W Albers
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

5.  MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

Authors:  Martin Köhrmann; Eric Jüttler; Jochen B Fiebach; Hagen B Huttner; Stefan Siebert; Christian Schwark; Peter A Ringleb; Peter D Schellinger; Werner Hacke
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

8.  Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

Review 9.  Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

Authors:  Mark O McCarron; James A R Nicoll
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

10.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321
View more
  1 in total

1.  Computed Tomography Angiography in the Assessment of Patients With Stroke/TIA.

Authors:  Bijoy K Menon; Andrew M Demchuk
Journal:  Neurohospitalist       Date:  2011-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.